KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer

Summary: Triple-negative breast cancers (TNBCs) display a complex spectrum of mutations and chromosomal aberrations. Chromosome 5q (5q) loss is detected in up to 70% of TNBCs, but little is known regarding the genetic drivers associated with this event. Here, we show somatic deletion of a region syn...

Full description

Bibliographic Details
Main Authors: Jennifer F. Knight, Vanessa Y.C. Sung, Elena Kuzmin, Amber L. Couzens, Danielle A. de Verteuil, Colin D.H. Ratcliffe, Paula P. Coelho, Radia M. Johnson, Payman Samavarchi-Tehrani, Tina Gruosso, Harvey W. Smith, Wontae Lee, Sadiq M. Saleh, Dongmei Zuo, Hong Zhao, Marie-Christine Guiot, Ryan R. Davis, Jeffrey P. Gregg, Christopher Moraes, Anne-Claude Gingras, Morag Park
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S221112471830305X
id doaj-f4500191f8be42e7bd824f4c692561b2
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jennifer F. Knight
Vanessa Y.C. Sung
Elena Kuzmin
Amber L. Couzens
Danielle A. de Verteuil
Colin D.H. Ratcliffe
Paula P. Coelho
Radia M. Johnson
Payman Samavarchi-Tehrani
Tina Gruosso
Harvey W. Smith
Wontae Lee
Sadiq M. Saleh
Dongmei Zuo
Hong Zhao
Marie-Christine Guiot
Ryan R. Davis
Jeffrey P. Gregg
Christopher Moraes
Anne-Claude Gingras
Morag Park
spellingShingle Jennifer F. Knight
Vanessa Y.C. Sung
Elena Kuzmin
Amber L. Couzens
Danielle A. de Verteuil
Colin D.H. Ratcliffe
Paula P. Coelho
Radia M. Johnson
Payman Samavarchi-Tehrani
Tina Gruosso
Harvey W. Smith
Wontae Lee
Sadiq M. Saleh
Dongmei Zuo
Hong Zhao
Marie-Christine Guiot
Ryan R. Davis
Jeffrey P. Gregg
Christopher Moraes
Anne-Claude Gingras
Morag Park
KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer
Cell Reports
author_facet Jennifer F. Knight
Vanessa Y.C. Sung
Elena Kuzmin
Amber L. Couzens
Danielle A. de Verteuil
Colin D.H. Ratcliffe
Paula P. Coelho
Radia M. Johnson
Payman Samavarchi-Tehrani
Tina Gruosso
Harvey W. Smith
Wontae Lee
Sadiq M. Saleh
Dongmei Zuo
Hong Zhao
Marie-Christine Guiot
Ryan R. Davis
Jeffrey P. Gregg
Christopher Moraes
Anne-Claude Gingras
Morag Park
author_sort Jennifer F. Knight
title KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer
title_short KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer
title_full KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer
title_fullStr KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer
title_full_unstemmed KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer
title_sort kibra (wwc1) is a metastasis suppressor gene affected by chromosome 5q loss in triple-negative breast cancer
publisher Elsevier
series Cell Reports
issn 2211-1247
publishDate 2018-03-01
description Summary: Triple-negative breast cancers (TNBCs) display a complex spectrum of mutations and chromosomal aberrations. Chromosome 5q (5q) loss is detected in up to 70% of TNBCs, but little is known regarding the genetic drivers associated with this event. Here, we show somatic deletion of a region syntenic with human 5q33.2–35.3 in a mouse model of TNBC. Mechanistically, we identify KIBRA as a major factor contributing to the effects of 5q loss on tumor growth and metastatic progression. Re-expression of KIBRA impairs metastasis in vivo and inhibits tumorsphere formation by TNBC cells in vitro. KIBRA functions co-operatively with the protein tyrosine phosphatase PTPN14 to trigger mechanotransduction-regulated signals that inhibit the nuclear localization of oncogenic transcriptional co-activators YAP/TAZ. Our results argue that the selective advantage produced by 5q loss involves reduced dosage of KIBRA, promoting oncogenic functioning of YAP/TAZ in TNBC. : Triple-negative breast cancers (TNBCs) frequently lose chromosome 5q. Using a TNBC mouse model with spontaneous loss of a syntenic region, Knight et al. identify KIBRA as a metastasis suppressor. Mechanistically, KIBRA suppresses RHOA activation, impairing nuclear translocation of the oncogenes YAP/TAZ, which drive metastatic and cancer stem cell-like behavior. Keywords: KIBRA, WWC1, PTPN14, YAP/TAZ, mechanotransduction, RHOA signaling, triple-negative breast cancer, metastasis, tumorspheres, chr5q
url http://www.sciencedirect.com/science/article/pii/S221112471830305X
work_keys_str_mv AT jenniferfknight kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT vanessaycsung kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT elenakuzmin kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT amberlcouzens kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT danielleadeverteuil kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT colindhratcliffe kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT paulapcoelho kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT radiamjohnson kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT paymansamavarchitehrani kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT tinagruosso kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT harveywsmith kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT wontaelee kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT sadiqmsaleh kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT dongmeizuo kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT hongzhao kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT mariechristineguiot kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT ryanrdavis kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT jeffreypgregg kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT christophermoraes kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT anneclaudegingras kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
AT moragpark kibrawwc1isametastasissuppressorgeneaffectedbychromosome5qlossintriplenegativebreastcancer
_version_ 1725897473252130816
spelling doaj-f4500191f8be42e7bd824f4c692561b22020-11-24T21:47:22ZengElsevierCell Reports2211-12472018-03-01221231913205KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast CancerJennifer F. Knight0Vanessa Y.C. Sung1Elena Kuzmin2Amber L. Couzens3Danielle A. de Verteuil4Colin D.H. Ratcliffe5Paula P. Coelho6Radia M. Johnson7Payman Samavarchi-Tehrani8Tina Gruosso9Harvey W. Smith10Wontae Lee11Sadiq M. Saleh12Dongmei Zuo13Hong Zhao14Marie-Christine Guiot15Ryan R. Davis16Jeffrey P. Gregg17Christopher Moraes18Anne-Claude Gingras19Morag Park20Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biochemistry, McGill University, Montreal, QC H2W 1S6, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biochemistry, McGill University, Montreal, QC H2W 1S6, CanadaLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biochemistry, McGill University, Montreal, QC H2W 1S6, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biochemistry, McGill University, Montreal, QC H2W 1S6, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, CanadaLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Oncology, McGill University, Montreal, QC H2W 1S6, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, CanadaDepartment of Biomedical Engineering, McGill University, Montreal, QC H3A 2B4, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, CanadaMontreal Neurological Institute, Department of Pathology, McGill University, Montreal, QC H3A 2B4, CanadaDepartment of Pathology and Laboratory Medicine, University of California at Davis School of Medicine, Sacramento, CA 95817, USADepartment of Pathology and Laboratory Medicine, University of California at Davis School of Medicine, Sacramento, CA 95817, USAGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biomedical Engineering, McGill University, Montreal, QC H3A 2B4, Canada; Department of Chemical Engineering, McGill University, Montreal, QC H3A 0C5, CanadaLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biochemistry, McGill University, Montreal, QC H2W 1S6, Canada; Department of Oncology, McGill University, Montreal, QC H2W 1S6, Canada; Corresponding authorSummary: Triple-negative breast cancers (TNBCs) display a complex spectrum of mutations and chromosomal aberrations. Chromosome 5q (5q) loss is detected in up to 70% of TNBCs, but little is known regarding the genetic drivers associated with this event. Here, we show somatic deletion of a region syntenic with human 5q33.2–35.3 in a mouse model of TNBC. Mechanistically, we identify KIBRA as a major factor contributing to the effects of 5q loss on tumor growth and metastatic progression. Re-expression of KIBRA impairs metastasis in vivo and inhibits tumorsphere formation by TNBC cells in vitro. KIBRA functions co-operatively with the protein tyrosine phosphatase PTPN14 to trigger mechanotransduction-regulated signals that inhibit the nuclear localization of oncogenic transcriptional co-activators YAP/TAZ. Our results argue that the selective advantage produced by 5q loss involves reduced dosage of KIBRA, promoting oncogenic functioning of YAP/TAZ in TNBC. : Triple-negative breast cancers (TNBCs) frequently lose chromosome 5q. Using a TNBC mouse model with spontaneous loss of a syntenic region, Knight et al. identify KIBRA as a metastasis suppressor. Mechanistically, KIBRA suppresses RHOA activation, impairing nuclear translocation of the oncogenes YAP/TAZ, which drive metastatic and cancer stem cell-like behavior. Keywords: KIBRA, WWC1, PTPN14, YAP/TAZ, mechanotransduction, RHOA signaling, triple-negative breast cancer, metastasis, tumorspheres, chr5qhttp://www.sciencedirect.com/science/article/pii/S221112471830305X